A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
Clinical trial NCT07198321 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07198321
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2027-09-22
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.